

16 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/spinogenix-announces-publication-of-preclinical-study-demonstrating-neuroprotective-effects-of-spg302-in-a-model-of-glaucoma-302586055.html

29 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/29/2889788/0/en/Spinogenix-Announces-FDA-Clearance-of-IND-Application-for-SPG302-a-Novel-Therapy-for-the-Treatment-of-ALS.html